Ranibizumab for Diabetic Macular Edema: Long-term Open-Label Extension of the Phase III Ride and Rise Trials

被引：0
|
作者：
Fung, Anne
Fu, Arthur
Zhang, Jiameng
Ehrlich, Jason S.
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
591-P
引用
收藏
页码：A151 / A152
页数：2
相关论文
共 50 条
  • [1] Ranibizumab for Diabetic Macular Edema: Long-Term Open-Label Extension of the Phase III RIDE and RISE Trials
    Ho, Allen C.
    Zhang, Jiameng
    Ehrlich, Jason S.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [2] Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials
    Wykoff, Charles C.
    Elman, Michael J.
    Regillo, Carl D.
    Ding, Beiying
    Lu, Na
    Stoilov, Ivaylo
    [J]. OPHTHALMOLOGY, 2016, 123 (08) : 1716 - 1721
  • [3] Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE
    Quan Dong Nguyen
    Brown, David M.
    Marcus, Dennis M.
    Boyer, David S.
    Patel, Sunil
    Feiner, Leonard
    Gibson, Andrea
    Sy, Judy
    Rundle, Amy Chen
    Hopkins, J. Jill
    Rubio, Roman G.
    Ehrlich, Jason S.
    [J]. OPHTHALMOLOGY, 2012, 119 (04) : 789 - 801
  • [4] Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials RISE and RIDE
    Brown, David M.
    Quan Dong Nguyen
    Marcus, Dennis M.
    Boyer, David S.
    Patel, Sunil
    Feiner, Leonard
    Schlottmann, Patricio G.
    Rundle, Amy Chen
    Zhang, Jiameng
    Rubio, Roman G.
    Adamis, Anthony P.
    Ehrlich, Jason S.
    Hopkins, J. Jill
    [J]. OPHTHALMOLOGY, 2013, 120 (10) : 2013 - 2022
  • [5] Durability of Diabetic Retinopathy Improvement with As-Needed Ranibizumab Open-Label Extension of RIDE and RISE Studies
    Sun, Jennifer K.
    Wang, Pin-wen
    Taylor, Sarah
    Haskova, Zdenka
    [J]. OPHTHALMOLOGY, 2019, 126 (05) : 712 - 720
  • [6] Effects of Intravitreal Ranibizumab on Retinal Hard Exudate in Diabetic Macular Edema Findings from the RIDE and RISE Phase III Clinical Trials
    Domalpally, Amitha
    Ip, Michael S.
    Ehrlich, Jason S.
    [J]. OPHTHALMOLOGY, 2015, 122 (04) : 779 - 786
  • [7] Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE
    Reddy, Rahul K.
    Pieramici, Dante J.
    Gune, Shamika
    Ghanekar, Avanti
    Lu, Na
    Quezada-Ruiz, Carlos
    Baumal, Caroline R.
    [J]. OPHTHALMOLOGY, 2018, 125 (10) : 1568 - 1574
  • [8] The top 10 findings from the RIDE/RISE trials of ranibizumab in patients with diabetic macular edema
    Singh, Rishi P.
    Tuomi, Lisa
    Stoilov, Ivaylo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [9] Clinically significant improvement in visual acuity and predictors of early vision gains in the RIDE and RISE Phase III trials of ranibizumab for diabetic macular edema
    Morse, Lawrence
    Yau, Linda
    Tuomi, Lisa
    Ehrlich, Jason
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [10] An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia
    Murakami, Masato
    Osada, Kenichi
    Ichibayashi, Hisao
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Ishida, Mitsuhiro
    Alev, Levent
    Nishioka, Kusuki
    [J]. MODERN RHEUMATOLOGY, 2017, 27 (04) : 688 - 695
12345